Prepared by FDA's Office of Planning and Evaluation in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER)
Joint Meeting of the Council on Drugs, American Medical Association with the Drug Research Board of the National Research Council (1971 : Washington, D.C. ?)